GOLDMAN SACHS GROUP INC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 66 filers reported holding UROGEN PHARMA LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$751,594
+131.4%
53,647
+70.9%
0.00%
Q2 2023$324,814
-50.2%
31,383
-55.5%
0.00%
Q1 2023$651,928
+213.1%
70,555
+200.6%
0.00%
Q4 2022$208,223
+6.2%
23,475
-0.5%
0.00%
Q3 2022$196,000
-37.4%
23,592
-38.3%
0.00%
Q2 2022$313,000
-27.9%
38,235
-23.1%
0.00%
Q1 2022$434,000
-15.4%
49,730
-7.9%
0.00%
Q4 2021$513,000
-46.7%
53,973
-5.6%
0.00%
Q3 2021$962,000
-8.7%
57,180
-17.2%
0.00%
Q2 2021$1,054,000
-47.7%
69,031
-33.2%
0.00%
-100.0%
Q1 2021$2,014,000
-36.2%
103,399
-41.0%
0.00%0.0%
Q4 2020$3,159,000
+2.6%
175,292
+9.8%
0.00%0.0%
Q3 2020$3,079,000
-17.7%
159,586
+11.4%
0.00%0.0%
Q2 2020$3,742,000
+75.4%
143,265
+19.8%
0.00%0.0%
Q1 2020$2,133,000
-32.0%
119,537
+27.2%
0.00%0.0%
Q4 2019$3,136,000
+3.8%
93,975
-25.8%
0.00%0.0%
Q3 2019$3,020,000
+45.8%
126,724
+119.8%
0.00%0.0%
Q2 2019$2,072,000
-5.6%
57,647
-3.0%
0.00%0.0%
Q1 2019$2,196,000
+215.1%
59,445
+267.4%
0.00%
Q4 2018$697,000
+20.6%
16,179
+32.2%
0.00%
Q3 2018$578,000
-23.4%
12,234
-19.4%
0.00%
Q2 2018$755,000
-66.0%
15,172
-66.1%
0.00%
-100.0%
Q1 2018$2,221,000
+849.1%
44,699
+609.5%
0.00%
Q4 2017$234,0006,3000.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q2 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
View complete list of UROGEN PHARMA LTD shareholders